CNS Embryology: From Tissue Origins to Clinical Anatomy

1. A. Anterior horn; basal plate (Best answer)

   Among these choices, anterior-horn dysfunction best fits a lower motor-neuron pattern with preserved sensation. These motor neurons arise from basal plate. The findings alone do not uniquely distinguish every possible motor axon or root disorder.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Anterior horn; basal plate,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Anterior horn; basal plate” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Anterior horn; basal plate,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Anterior horn; basal plate” remains viable only if both steps agree.

2. B. Skeletal muscle; somite myotome (Why this does not fit)

   Myotome supplies skeletal muscle, but fasciculations, motor-unit loss and direct muscle responsiveness point to neuronal rather than primary muscle failure.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Skeletal muscle; somite myotome,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Skeletal muscle; somite myotome” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Skeletal muscle; somite myotome,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Skeletal muscle; somite myotome” remains viable only if both steps agree.

3. C. Anterior horn; alar plate (Why this does not fit)

   Anterior-horn localization fits the motor findings, but alar plate gives dorsal sensory domains, not these motor neurons.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Anterior horn; alar plate,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Anterior horn; alar plate” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Anterior horn; alar plate,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Anterior horn; alar plate” remains viable only if both steps agree.

4. D. Dorsal-root ganglion; neural crest (Why this does not fit)

   Crest supplies sensory ganglia, but preserved sensation and sensory responses oppose a primary sensory-ganglion lesion.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Dorsal-root ganglion; neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Dorsal-root ganglion; neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Dorsal-root ganglion; neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Dorsal-root ganglion; neural crest” remains viable only if both steps agree.

Takeaway: Localize the impaired motor unit before assigning the basal-plate origin.

Case sources: ^{[1] [2]}

1. A. Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the primitive-myeloid label (Why this does not fit)

   Both assignments conflict with the evidence: resident microglia persist from the early myeloid population, while oligodendrocytes belong to neuroepithelium.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the primitive-myeloid label,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the primitive-myeloid label” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the primitive-myeloid label,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the primitive-myeloid label” remains viable only if both steps agree.

2. B. Parenchymal phagocytes retain the embryonic label; myelinating cells carry the neuroepithelial label (Best answer)

   Resident microglia derive from primitive myeloid progenitors and maintain themselves at steady state; oligodendrocytes derive from neural neuroepithelium.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the neuroepithelial label,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the neuroepithelial label” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the neuroepithelial label,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the neuroepithelial label” remains viable only if both steps agree.

3. C. Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the neuroepithelial label (Why this does not fit)

   The myelinating-cell ancestry is right, but steady-state microglia are not normally replaced wholesale by circulating donor monocytes.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the neuroepithelial label,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the neuroepithelial label” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the neuroepithelial label,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Parenchymal phagocytes acquire the blood-donor label; myelinating cells carry the neuroepithelial label” remains viable only if both steps agree.

4. D. Parenchymal phagocytes retain the embryonic label; myelinating cells carry the primitive-myeloid label (Why this does not fit)

   This preserves microglial ancestry but incorrectly assigns oligodendrocytes to the myeloid rather than neuroepithelial lineage.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the primitive-myeloid label,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the primitive-myeloid label” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the primitive-myeloid label,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Parenchymal phagocytes retain the embryonic label; myelinating cells carry the primitive-myeloid label” remains viable only if both steps agree.

Takeaway: Cell function, embryonic labeling and adult replacement distinguish microglia from oligodendrocytes.

Case sources: ^{[7] [34]}

1. A. Dermatome of a somite (Why this does not fit)

   Dermatome is an adjacent somitic subdivision, but produces dermal rather than central intervertebral-disc tissue.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Dermatome of a somite,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Dermatome of a somite” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Dermatome of a somite,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Dermatome of a somite” remains viable only if both steps agree.

2. B. Neural-tube neuroepithelium (Why this does not fit)

   Radicular symptoms suggest neural compression, but the excised tissue is the gelatinous disc center rather than the compressed nerve or spinal cord.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Neural-tube neuroepithelium,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural-tube neuroepithelium” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Neural-tube neuroepithelium,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural-tube neuroepithelium” remains viable only if both steps agree.

3. C. Embryonic notochord (Best answer)

   The central gelatinous material is nucleus pulposus, conventionally associated with notochordal origin. Mouse fate mapping directly supports this lineage; the human surgical finding identifies the compartment rather than performing a lineage experiment.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Embryonic notochord,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Embryonic notochord” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Embryonic notochord,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Embryonic notochord” remains viable only if both steps agree.

4. D. Sclerotome of paraxial mesoderm (Why this does not fit)

   Sclerotome supplies surrounding annulus and vertebral tissues, making it a credible alternative for a disc specimen. The excised gelatinous central compartment instead points to nucleus pulposus.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Sclerotome of paraxial mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Sclerotome of paraxial mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Sclerotome of paraxial mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Sclerotome of paraxial mesoderm” remains viable only if both steps agree.

Takeaway: Identify the excised disc compartment before assigning its notochordal origin; the surrounding annulus has a different origin.

Case sources: ^[28]

1. A. Myelencephalon (Why this does not fit)

   Tempting because it surrounds the inferior fourth ventricle. However, the enlargement is confined to paired hemispheric cavities.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Myelencephalon,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Myelencephalon” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Myelencephalon,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Myelencephalon” remains viable only if both steps agree.

2. B. Diencephalon (Why this does not fit)

   Tempting because the third ventricle lies immediately downstream of the foramina. However, its ventricle is normal-sized.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Diencephalon,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Diencephalon” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Diencephalon,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Diencephalon” remains viable only if both steps agree.

3. C. Mesencephalon (Why this does not fit)

   Tempting because aqueduct obstruction often enlarges lateral ventricles. However, it would also enlarge the third ventricle.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Mesencephalon,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Mesencephalon” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Mesencephalon,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Mesencephalon” remains viable only if both steps agree.

4. D. Metencephalon (Why this does not fit)

   Tempting because its lumen contributes to the fourth ventricle. However, the fourth ventricle is not dilated.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Metencephalon,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Metencephalon” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Metencephalon,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Metencephalon” remains viable only if both steps agree.

5. E. Telencephalon (Best answer)

   The paired hemispheric cavities are lateral ventricles, whose walls derive from telencephalon. Their isolated enlargement with a normal third ventricle favors obstruction at their exits rather than at the aqueduct.

   Reasoning steps for option E

   1. What stem feature must be localized before judging option E, “Telencephalon,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Telencephalon” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option E, “Telencephalon,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Telencephalon” remains viable only if both steps agree.

Takeaway: Map paired cerebral lumens to telencephalon.

Case sources: ^[33]

1. A. Metencephalon; cerebellum (Best answer)

   Ipsilateral facial/abducens findings with contralateral limb weakness indicate a pontine lesion; both pons and cerebellum arise from metencephalon.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Metencephalon; cerebellum,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Metencephalon; cerebellum” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Metencephalon; cerebellum,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Metencephalon; cerebellum” remains viable only if both steps agree.

2. B. Mesencephalon; cerebellum (Why this does not fit)

   Neither assignment fits: midbrain is mesencephalic, while cerebellum is metencephalic.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Mesencephalon; cerebellum,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Mesencephalon; cerebellum” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Mesencephalon; cerebellum,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Mesencephalon; cerebellum” remains viable only if both steps agree.

3. C. Metencephalon; medulla (Why this does not fit)

   The pontine localization is metencephalic, but medulla belongs to myelencephalon.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Metencephalon; medulla,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Metencephalon; medulla” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Metencephalon; medulla,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Metencephalon; medulla” remains viable only if both steps agree.

4. D. Myelencephalon; medulla (Why this does not fit)

   This vesicle-derivative pair is internally correct but does not match the pontine facial/abducens pattern.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Myelencephalon; medulla,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Myelencephalon; medulla” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Myelencephalon; medulla,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Myelencephalon; medulla” remains viable only if both steps agree.

Takeaway: Brainstem localization must precede transfer to another derivative of the same vesicle.

Case sources: ^{[1] [33] [45]}

1. A. Mesencephalon; aqueduct (Why this does not fit)

   That pair is anatomically correct but would favor midbrain ocular motor findings rather than this bulbar pattern.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Mesencephalon; aqueduct,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Mesencephalon; aqueduct” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Mesencephalon; aqueduct,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Mesencephalon; aqueduct” remains viable only if both steps agree.

2. B. Myelencephalon; caudal fourth ventricle (Best answer)

   Crossed bulbar and body findings localize to medulla; medulla develops from myelencephalon beside the caudal fourth ventricle.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Myelencephalon; caudal fourth ventricle,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Myelencephalon; caudal fourth ventricle” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Myelencephalon; caudal fourth ventricle,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Myelencephalon; caudal fourth ventricle” remains viable only if both steps agree.

3. C. Metencephalon; rostral fourth ventricle (Why this does not fit)

   This correctly pairs pons with rostral fourth ventricle but does not fit the lower cranial motor pattern with crossed body findings.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Metencephalon; rostral fourth ventricle,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Metencephalon; rostral fourth ventricle” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Metencephalon; rostral fourth ventricle,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Metencephalon; rostral fourth ventricle” remains viable only if both steps agree.

4. D. Myelencephalon; cerebral aqueduct (Why this does not fit)

   The bulbar localization is myelencephalic, but the aqueduct belongs to mesencephalon.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Myelencephalon; cerebral aqueduct,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Myelencephalon; cerebral aqueduct” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Myelencephalon; cerebral aqueduct,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Myelencephalon; cerebral aqueduct” remains viable only if both steps agree.

Takeaway: Infer the medullary localization before naming its vesicle and cavity.

Case sources: ^{[1] [33] [45]}

1. A. Pontine nuclei (Why this does not fit)

   Pons is metencephalic, not forebrain optic or infundibular tissue.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Pontine nuclei,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Pontine nuclei” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Pontine nuclei,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Pontine nuclei” remains viable only if both steps agree.

2. B. Lens placode (Why this does not fit)

   Lens is surface ectoderm and explicitly formed, unlike neural retina.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Lens placode,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Lens placode” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Lens placode,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Lens placode” remains viable only if both steps agree.

3. C. Thalamic primordium (Best answer)

   Retinal neural tissue and the infundibular posterior pituitary arise from diencephalic neuroectoderm; thalamus is another diencephalic structure.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Thalamic primordium,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Thalamic primordium” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Thalamic primordium,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Thalamic primordium” remains viable only if both steps agree.

4. D. Cerebral cortical plate (Why this does not fit)

   Cerebral cortex derives from telencephalon rather than the diencephalic compartment shared by optic and infundibular outgrowths.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Cerebral cortical plate,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cerebral cortical plate” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Cerebral cortical plate,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cerebral cortical plate” remains viable only if both steps agree.

5. E. Midbrain tectum (Why this does not fit)

   The tectum is mesencephalic, while the optic and infundibular outgrowths point to diencephalon.

   Reasoning steps for option E

   1. What stem feature must be localized before judging option E, “Midbrain tectum,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Midbrain tectum” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option E, “Midbrain tectum,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Midbrain tectum” remains viable only if both steps agree.

Takeaway: Identify a shared diencephalic compartment from its outgrowths, then identify another normal derivative without assuming obligatory co-malformation.

Case sources: ^{[35] [3] [33]}

1. A. Peripheral motor and sensory nerves; neural crest (Why this does not fit)

   Peripheral myelin and neural crest fit Schwann population B, not the multiple-axon population A.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Peripheral motor and sensory nerves; neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Peripheral motor and sensory nerves; neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Peripheral motor and sensory nerves; neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Peripheral motor and sensory nerves; neural crest” remains viable only if both steps agree.

2. B. Optic pathway and cerebral white matter; neural crest (Why this does not fit)

   The distribution fits CNS myelin, but neural crest is the origin of peripheral Schwann cells, not oligodendrocytes.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Optic pathway and cerebral white matter; neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Optic pathway and cerebral white matter; neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Optic pathway and cerebral white matter; neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Optic pathway and cerebral white matter; neural crest” remains viable only if both steps agree.

3. C. Peripheral motor and sensory nerves; neural tube (Why this does not fit)

   Neural-tube ancestry fits A, but the peripheral distribution belongs to Schwann rather than oligodendrocyte myelin.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Peripheral motor and sensory nerves; neural tube,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Peripheral motor and sensory nerves; neural tube” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Peripheral motor and sensory nerves; neural tube,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Peripheral motor and sensory nerves; neural tube” remains viable only if both steps agree.

4. D. Optic pathway and cerebral white matter; neural tube (Best answer)

   Multiple internodes on different CNS axons identify oligodendrocytes; their neuroepithelial lineage matches CNS optic and cerebral myelin.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Optic pathway and cerebral white matter; neural tube,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Optic pathway and cerebral white matter; neural tube” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Optic pathway and cerebral white matter; neural tube,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Optic pathway and cerebral white matter; neural tube” remains viable only if both steps agree.

Takeaway: Infer the myelinating cell from internode organization, then predict the affected nervous-system compartment and its embryonic origin.

Case sources: ^{[1] [16] [34] [35]}

1. A. Absent submucosal ganglia; impaired enteric neural crest colonization (Best answer)

   Distal functional obstruction and absent inhibitory relaxation suggest Hirschsprung disease; absent submucosal ganglia on an adequate suction biopsy support deficient enteric crest development.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Absent submucosal ganglia; impaired enteric neural crest colonization,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Absent submucosal ganglia; impaired enteric neural crest colonization” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Absent submucosal ganglia; impaired enteric neural crest colonization,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Absent submucosal ganglia; impaired enteric neural crest colonization” remains viable only if both steps agree.

2. B. Preserved submucosal ganglia; failure of endodermal epithelial differentiation (Why this does not fit)

   This does not explain the characteristic distal functional obstruction with abnormal relaxation; the proposed epithelial process does not specify enteric aganglionosis.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Preserved submucosal ganglia; failure of endodermal epithelial differentiation,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Preserved submucosal ganglia; failure of endodermal epithelial differentiation” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Preserved submucosal ganglia; failure of endodermal epithelial differentiation,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Preserved submucosal ganglia; failure of endodermal epithelial differentiation” remains viable only if both steps agree.

3. C. Preserved submucosal ganglia; impaired enteric neural crest colonization (Why this does not fit)

   The process identifies the relevant enteric lineage, but a persistently aganglionic distal segment should lack, not preserve, its ganglion cells.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Preserved submucosal ganglia; impaired enteric neural crest colonization,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Preserved submucosal ganglia; impaired enteric neural crest colonization” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Preserved submucosal ganglia; impaired enteric neural crest colonization,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Preserved submucosal ganglia; impaired enteric neural crest colonization” remains viable only if both steps agree.

4. D. Absent submucosal ganglia; failure of endodermal epithelial differentiation (Why this does not fit)

   Absent ganglia fit Hirschsprung disease, but their missing cells are neural crest-derived rather than gut epithelial endoderm.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Absent submucosal ganglia; failure of endodermal epithelial differentiation,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Absent submucosal ganglia; failure of endodermal epithelial differentiation” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Absent submucosal ganglia; failure of endodermal epithelial differentiation,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Absent submucosal ganglia; failure of endodermal epithelial differentiation” remains viable only if both steps agree.

Takeaway: Infer a functional distal obstruction, then predict neuronal histology and the failed developmental population.

Case sources: ^{[16] [22] [36]}

1. A. Enteric neurons: mesoderm; pigment cells: surface ectoderm (Why this does not fit)

   This confuses the bowel muscle and epidermal surroundings with the neuronal and melanocyte populations actually affected.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Enteric neurons: mesoderm; pigment cells: surface ectoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Enteric neurons: mesoderm; pigment cells: surface ectoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Enteric neurons: mesoderm; pigment cells: surface ectoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Enteric neurons: mesoderm; pigment cells: surface ectoderm” remains viable only if both steps agree.

2. B. Enteric neurons: neural crest; pigment cells: neural crest (Best answer)

   Aganglionosis and pigment-associated deafness can involve two crest-derived populations. This does not assign otic sensory epithelium or the entire inner ear to crest.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Enteric neurons: neural crest; pigment cells: neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Enteric neurons: neural crest; pigment cells: neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Enteric neurons: neural crest; pigment cells: neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Enteric neurons: neural crest; pigment cells: neural crest” remains viable only if both steps agree.

3. C. Enteric neurons: neural crest; pigment cells: surface ectoderm (Why this does not fit)

   The enteric origin fits, but skin location does not make melanocytes surface-ectoderm derivatives.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Enteric neurons: neural crest; pigment cells: surface ectoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Enteric neurons: neural crest; pigment cells: surface ectoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Enteric neurons: neural crest; pigment cells: surface ectoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Enteric neurons: neural crest; pigment cells: surface ectoderm” remains viable only if both steps agree.

4. D. Enteric neurons: neural tube; pigment cells: neural crest (Why this does not fit)

   The pigment-cell origin fits, but enteric neurons colonize the bowel from neural crest rather than developing from CNS neuroepithelium.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Enteric neurons: neural tube; pigment cells: neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Enteric neurons: neural tube; pigment cells: neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Enteric neurons: neural tube; pigment cells: neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Enteric neurons: neural tube; pigment cells: neural crest” remains viable only if both steps agree.

Takeaway: A shared neural crest origin can connect pigment, hearing and enteric findings without making all ear tissues one lineage.

Case sources: ^{[18] [21] [22]}

1. A. Impair both cranial neural crest and cranial mesoderm (Why this does not fit)

   This could damage facial skeleton but does not directly spare the muscle precursors specified in the question.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Impair both cranial neural crest and cranial mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Impair both cranial neural crest and cranial mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Impair both cranial neural crest and cranial mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Impair both cranial neural crest and cranial mesoderm” remains viable only if both steps agree.

2. B. Impair remaining CNS neuroepithelium after crest departure; preserve cranial mesoderm (Why this does not fit)

   After the crest population has already separated, selective disruption of remaining CNS neuroepithelium does not directly reproduce loss of the migrated craniofacial skeletal precursors.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Impair remaining CNS neuroepithelium after crest departure; preserve cranial mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Impair remaining CNS neuroepithelium after crest departure; preserve cranial mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Impair remaining CNS neuroepithelium after crest departure; preserve cranial mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Impair remaining CNS neuroepithelium after crest departure; preserve cranial mesoderm” remains viable only if both steps agree.

3. C. Impair cranial neural crest; preserve cranial mesoderm (Best answer)

   Much of this facial skeleton comes from cranial crest, while branchiomeric muscle precursors are mesodermal; selective skeletal loss can therefore coexist with formed muscles.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Impair cranial neural crest; preserve cranial mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Impair cranial neural crest; preserve cranial mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Impair cranial neural crest; preserve cranial mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Impair cranial neural crest; preserve cranial mesoderm” remains viable only if both steps agree.

4. D. Impair cranial mesoderm; preserve cranial neural crest (Why this does not fit)

   This reverses the principal skeletal-muscle distinction: preserved crest favors formed facial skeleton, while impaired mesoderm threatens muscle development.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Impair cranial mesoderm; preserve cranial neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Impair cranial mesoderm; preserve cranial neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Impair cranial mesoderm; preserve cranial neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Impair cranial mesoderm; preserve cranial neural crest” remains viable only if both steps agree.

Takeaway: Separate craniofacial skeletal cells from adjacent muscle before predicting a selective developmental perturbation.

Case sources: ^{[16] [18] [23] [36]}

1. A. Second heart field myocardium (Why this does not fit)

   Second heart field cells contribute myocardium and outflow growth, but this choice does not account for the linked thymic and calcium findings.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Second heart field myocardium,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Second heart field myocardium” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Second heart field myocardium,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Second heart field myocardium” remains viable only if both steps agree.

2. B. Proepicardial mesothelium (Why this does not fit)

   Proepicardial derivatives contribute epicardial and coronary stromal tissues rather than the combined outflow-septation and pharyngeal pattern described.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Proepicardial mesothelium,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Proepicardial mesothelium” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Proepicardial mesothelium,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Proepicardial mesothelium” remains viable only if both steps agree.

3. C. Atrioventricular endocardial cushion mesenchyme (Why this does not fit)

   Endocardial cushion tissue is central to atrioventricular septal and valvar development, but it does not unify this distal outflow defect with the thymic and calcium findings.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Atrioventricular endocardial cushion mesenchyme,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Atrioventricular endocardial cushion mesenchyme” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Atrioventricular endocardial cushion mesenchyme,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Atrioventricular endocardial cushion mesenchyme” remains viable only if both steps agree.

4. D. Cardiac neural crest migrating through the pharyngeal region (Best answer)

   Persistent truncus plus thymic and parathyroid-region abnormalities points to a developmental territory in which cardiac neural crest migration is important for outflow septation and pharyngeal arch derivatives.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Cardiac neural crest migrating through the pharyngeal region,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cardiac neural crest migrating through the pharyngeal region” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Cardiac neural crest migrating through the pharyngeal region,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cardiac neural crest migrating through the pharyngeal region” remains viable only if both steps agree.

Takeaway: Match the observed arterial partition defect to a normal developmental contribution without claiming a single exclusive cause.

Case sources: ^{[8] [9] [24]}

1. A. Adrenal medulla; neural crest (Best answer)

   Metanephrine excess identifies a catecholamine-producing medullary tumor; chromaffin ancestry is neural crest, distinct from the surrounding cortex.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Adrenal medulla; neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Adrenal medulla; neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Adrenal medulla; neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Adrenal medulla; neural crest” remains viable only if both steps agree.

2. B. Adrenal cortex; mesoderm (Why this does not fit)

   This is the correct origin of steroid-producing cortex, but excess metanephrines indicate catecholamine metabolism rather than cortical steroid production.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Adrenal cortex; mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Adrenal cortex; mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Adrenal cortex; mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Adrenal cortex; mesoderm” remains viable only if both steps agree.

3. C. Adrenal medulla; mesoderm (Why this does not fit)

   The secretory compartment is correct, but chromaffin cells belong to the neural crest-derived sympathoadrenal lineage.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Adrenal medulla; mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Adrenal medulla; mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Adrenal medulla; mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Adrenal medulla; mesoderm” remains viable only if both steps agree.

4. D. Adrenal cortex; neural crest (Why this does not fit)

   Neither component fits: the biochemical pattern points to medulla, and cortex is mesodermal.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Adrenal cortex; neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Adrenal cortex; neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Adrenal cortex; neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Adrenal cortex; neural crest” remains viable only if both steps agree.

Takeaway: Interpret the hormone products before assigning the adrenal compartment and lineage.

Case sources: ^{[16] [26] [36]}

1. A. Diencephalic infundibulum; anterior somatotrophs (Why this does not fit)

   Somatotroph impairment explains low IGF-1, but the classic epithelial association of an adamantinomatous craniopharyngioma is Rathke-region oral ectoderm, not infundibulum.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Diencephalic infundibulum; anterior somatotrophs,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Diencephalic infundibulum; anterior somatotrophs” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Diencephalic infundibulum; anterior somatotrophs,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Diencephalic infundibulum; anterior somatotrophs” remains viable only if both steps agree.

2. B. Rathke-region oral ectoderm; anterior somatotrophs (Best answer)

   A calcified cystic childhood suprasellar lesion suggests adamantinomatous craniopharyngioma. Its traditional Rathke-region epithelial association differs from posterior neural pituitary. Disruption of hypothalamic-pituitary GH function reduces the growth signal normally supplied by anterior somatotrophs.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Rathke-region oral ectoderm; anterior somatotrophs,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Rathke-region oral ectoderm; anterior somatotrophs” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Rathke-region oral ectoderm; anterior somatotrophs,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Rathke-region oral ectoderm; anterior somatotrophs” remains viable only if both steps agree.

3. C. Rathke-region oral ectoderm; posterior vasopressin terminals (Why this does not fit)

   The lesion association is appropriate, but posterior vasopressin disruption predicts water-balance abnormalities rather than directly explaining the low-IGF-1 growth pattern.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Rathke-region oral ectoderm; posterior vasopressin terminals,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Rathke-region oral ectoderm; posterior vasopressin terminals” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Rathke-region oral ectoderm; posterior vasopressin terminals,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Rathke-region oral ectoderm; posterior vasopressin terminals” remains viable only if both steps agree.

4. D. Diencephalic infundibulum; posterior vasopressin terminals (Why this does not fit)

   This pairing fits posterior pituitary development and water balance, not the likely epithelial tumor association and GH-related growth deficit.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Diencephalic infundibulum; posterior vasopressin terminals,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Diencephalic infundibulum; posterior vasopressin terminals” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Diencephalic infundibulum; posterior vasopressin terminals,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Diencephalic infundibulum; posterior vasopressin terminals” remains viable only if both steps agree.

Takeaway: Identify the likely tumor pattern, then distinguish its epithelial developmental association from the affected GH axis and its hormone-producing cells.

Case sources: ^{[3] [32] [44]}

1. A. Diencephalic neuroectoderm (Why this does not fit)

   Diencephalic neural ectoderm forms the posterior pituitary, whose water-balance role is functionally preserved here; the deficient trophic hormones point instead to anterior lobe.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Diencephalic neuroectoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Diencephalic neuroectoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Diencephalic neuroectoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Diencephalic neuroectoderm” remains viable only if both steps agree.

2. B. Neural crest (Why this does not fit)

   Tempting because some peripheral endocrine cells are crest-derived. However, multiple anterior pituitary trophic hormones are deficient.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Neural crest,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural crest” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Neural crest,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural crest” remains viable only if both steps agree.

3. C. Foregut endoderm (Why this does not fit)

   Tempting because some endocrine organs arise from endoderm. However, the affected hormone producers are adenohypophyseal.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Foregut endoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Foregut endoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Foregut endoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Foregut endoderm” remains viable only if both steps agree.

4. D. Paraxial mesoderm (Why this does not fit)

   Tempting because mesoderm contributes sellar surrounding tissue. However, it is not the origin of ACTH, TSH, and GH secreting cells.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Paraxial mesoderm,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Paraxial mesoderm” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Paraxial mesoderm,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Paraxial mesoderm” remains viable only if both steps agree.

5. E. Oral ectodermal Rathke pouch (Best answer)

   Deficient ACTH, TSH and GH point to the adenohypophysis, derived from oral ectodermal Rathke pouch. Preserved water balance supports functional separation from the posterior neural lobe.

   Reasoning steps for option E

   1. What stem feature must be localized before judging option E, “Oral ectodermal Rathke pouch,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Oral ectodermal Rathke pouch” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option E, “Oral ectodermal Rathke pouch,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Oral ectodermal Rathke pouch” remains viable only if both steps agree.

Takeaway: Rule out posterior neural origin.

Case sources: ^[3]

1. A. The two secretory products require different germ layers; the human expression results establish direct lineage tracing (Why this does not fit)

   Distinct hormone function does not establish distinct germ layers, and expression studies are not direct human embryonic fate maps.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “The two secretory products require different germ layers; the human expression results establish direct lineage tracing,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “The two secretory products require different germ layers; the human expression results establish direct lineage tracing” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “The two secretory products require different germ layers; the human expression results establish direct lineage tracing,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “The two secretory products require different germ layers; the human expression results establish direct lineage tracing” remains viable only if both steps agree.

2. B. Shared endodermal labeling makes the tumor follicular; the human results remain indirect (Why this does not fit)

   The evidence-scope qualification is correct, but shared ancestry does not erase the functional and pathological distinction between C cells and follicles.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Shared endodermal labeling makes the tumor follicular; the human results remain indirect,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Shared endodermal labeling makes the tumor follicular; the human results remain indirect” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Shared endodermal labeling makes the tumor follicular; the human results remain indirect,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Shared endodermal labeling makes the tumor follicular; the human results remain indirect” remains viable only if both steps agree.

3. C. Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human lineage inference remains indirect (Best answer)

   The tumor retains C-cell differentiation despite a germ-layer ancestry shared with follicles in the mouse experiment. Human expression evidence supports, rather than directly fate-maps, the analogous lineage.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human lineage inference remains indirect,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human lineage inference remains indirect” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human lineage inference remains indirect,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human lineage inference remains indirect” remains viable only if both steps agree.

4. D. Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human results directly fate-map the same cells (Why this does not fit)

   The mouse conclusion is correct, but the human part overstates expression evidence as direct developmental tracing.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human results directly fate-map the same cells,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human results directly fate-map the same cells” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human results directly fate-map the same cells,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Distinct C-cell and follicular functions can share endodermal ancestry in mice; the human results directly fate-map the same cells” remains viable only if both steps agree.

Takeaway: Keep functional cell identity separate from germ-layer ancestry and distinguish experimental lineage tracing from supportive human expression.

Case sources: ^{[4] [26]}

1. A. Fusion of the caudal spinal arches (Why this does not fit)

   Tempting because open spinal defects can increase AFP. However, the lesion is cranial, not spinal.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Fusion of the caudal spinal arches,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Fusion of the caudal spinal arches” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Fusion of the caudal spinal arches,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Fusion of the caudal spinal arches” remains viable only if both steps agree.

2. B. Maintenance of cerebral-aqueduct patency (Why this does not fit)

   Aqueduct narrowing can obstruct CSF and cause hydrocephalus within an existing cranial vault; it does not explain exposed cranial neural tissue and absent calvarium.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Maintenance of cerebral-aqueduct patency,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Maintenance of cerebral-aqueduct patency” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Maintenance of cerebral-aqueduct patency,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Maintenance of cerebral-aqueduct patency” remains viable only if both steps agree.

3. C. Expansion of the cerebellar vermis (Why this does not fit)

   Tempting because posterior-fossa anomalies affect hindbrain. However, the anterior vault is absent.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Expansion of the cerebellar vermis,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Expansion of the cerebellar vermis” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Expansion of the cerebellar vermis,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Expansion of the cerebellar vermis” remains viable only if both steps agree.

4. D. Separation of the forebrain into two hemispheres (Why this does not fit)

   Tempting because a midline brain defect can have facial anomalies. However, absent calvarium and exposed tissue favor cranial closure failure.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Separation of the forebrain into two hemispheres,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Separation of the forebrain into two hemispheres” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Separation of the forebrain into two hemispheres,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Separation of the forebrain into two hemispheres” remains viable only if both steps agree.

5. E. Closure of the cranial neural tube (Best answer)

   The absent cranial vault and exposed disorganized neural tissue fit the acrania-exencephaly-anencephaly spectrum following failed cranial neural-tube closure. Failed forebrain separation does not explain this exposed cranial pattern.

   Reasoning steps for option E

   1. What stem feature must be localized before judging option E, “Closure of the cranial neural tube,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Closure of the cranial neural tube” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option E, “Closure of the cranial neural tube,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Closure of the cranial neural tube” remains viable only if both steps agree.

Takeaway: Map to failed cranial tube closure.

Case sources: ^{[40] [2]}

1. A. Neural-containing encephalocele; intact coverage limited fetal protein leakage (Best answer)

   Cortical continuity identifies neural tissue within the sac. At an appropriate screening age, intact coverage can limit leakage and permit a negative AFP result.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Neural-containing encephalocele; intact coverage limited fetal protein leakage,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural-containing encephalocele; intact coverage limited fetal protein leakage” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Neural-containing encephalocele; intact coverage limited fetal protein leakage,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural-containing encephalocele; intact coverage limited fetal protein leakage” remains viable only if both steps agree.

2. B. Neural-containing encephalocele; the sample preceded the useful midtrimester AFP window (Why this does not fit)

   The sac classification fits, but 17 weeks is within the usual screening window, not before it.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Neural-containing encephalocele; the sample preceded the useful midtrimester AFP window,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural-containing encephalocele; the sample preceded the useful midtrimester AFP window” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Neural-containing encephalocele; the sample preceded the useful midtrimester AFP window,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural-containing encephalocele; the sample preceded the useful midtrimester AFP window” remains viable only if both steps agree.

3. C. Cranial meningocele without neural tissue; intact coverage limited fetal protein leakage (Why this does not fit)

   Coverage explains the negative screen, but a meninges-only sac does not explain tissue continuous with intracranial cortex.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Cranial meningocele without neural tissue; intact coverage limited fetal protein leakage,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cranial meningocele without neural tissue; intact coverage limited fetal protein leakage” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Cranial meningocele without neural tissue; intact coverage limited fetal protein leakage,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cranial meningocele without neural tissue; intact coverage limited fetal protein leakage” remains viable only if both steps agree.

4. D. Cranial meningocele without neural tissue; the sample preceded the useful midtrimester AFP window (Why this does not fit)

   This conflicts with both cortical continuity and the appropriately timed 17-week serum sample.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Cranial meningocele without neural tissue; the sample preceded the useful midtrimester AFP window,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cranial meningocele without neural tissue; the sample preceded the useful midtrimester AFP window” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Cranial meningocele without neural tissue; the sample preceded the useful midtrimester AFP window,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cranial meningocele without neural tissue; the sample preceded the useful midtrimester AFP window” remains viable only if both steps agree.

Takeaway: Use sac contents to classify the lesion and coverage plus sampling age to interpret a negative screen.

Case sources: ^{[10] [40] [46]}

1. A. Neural tissue and meninges; an intact skin-covered lesion (Why this does not fit)

   Neural contents fit the deficits, but intact coverage would provide a less direct explanation for the AFP elevation.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Neural tissue and meninges; an intact skin-covered lesion,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural tissue and meninges; an intact skin-covered lesion” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Neural tissue and meninges; an intact skin-covered lesion,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural tissue and meninges; an intact skin-covered lesion” remains viable only if both steps agree.

2. B. Neural tissue and meninges; an uncovered lesion (Best answer)

   The deficits favor neural tissue involvement, and elevated AFP supports prenatal exposure permitting protein leakage. These findings predict myelomeningocele; imaging and examination are still needed to confirm anatomy.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Neural tissue and meninges; an uncovered lesion,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural tissue and meninges; an uncovered lesion” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Neural tissue and meninges; an uncovered lesion,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural tissue and meninges; an uncovered lesion” remains viable only if both steps agree.

3. C. Meninges without neural tissue; an uncovered lesion (Why this does not fit)

   The serum result favors exposure, but motor and sacral deficits favor neural involvement rather than a meninges-only sac.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Meninges without neural tissue; an uncovered lesion,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Meninges without neural tissue; an uncovered lesion” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Meninges without neural tissue; an uncovered lesion,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Meninges without neural tissue; an uncovered lesion” remains viable only if both steps agree.

4. D. Meninges without neural tissue; an intact skin-covered lesion (Why this does not fit)

   This does not best integrate either the segmental neurological deficits or the appropriately timed elevated AFP.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Meninges without neural tissue; an intact skin-covered lesion,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Meninges without neural tissue; an intact skin-covered lesion” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Meninges without neural tissue; an intact skin-covered lesion,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Meninges without neural tissue; an intact skin-covered lesion” remains viable only if both steps agree.

Takeaway: Integrate neurological function with a properly contextualized serum result to predict both sac contents and coverage.

Case sources: ^{[10] [40] [41]}

1. A. Sclerotome; leakage from an exposed neural placode (Why this does not fit)

   The bony origin fits, but imaging shows intact coverage without an exposed neural placode.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Sclerotome; leakage from an exposed neural placode,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Sclerotome; leakage from an exposed neural placode” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Sclerotome; leakage from an exposed neural placode,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Sclerotome; leakage from an exposed neural placode” remains viable only if both steps agree.

2. B. Neural crest; little direct leakage through intact coverage (Why this does not fit)

   The screening mechanism fits a closed defect, but posterior vertebral elements are somite-sclerotomal rather than crest-derived.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Neural crest; little direct leakage through intact coverage,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural crest; little direct leakage through intact coverage” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Neural crest; little direct leakage through intact coverage,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural crest; little direct leakage through intact coverage” remains viable only if both steps agree.

3. C. Sclerotome; little direct leakage through intact coverage (Best answer)

   The posterior bony elements arise from sclerotome. Intact skin and absence of exposed neural tissue reduce direct fetal protein leakage, allowing a normal serum screen despite the defect.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Sclerotome; little direct leakage through intact coverage,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Sclerotome; little direct leakage through intact coverage” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Sclerotome; little direct leakage through intact coverage,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Sclerotome; little direct leakage through intact coverage” remains viable only if both steps agree.

4. D. Neural crest; leakage from an exposed neural placode (Why this does not fit)

   This misassigns vertebral lineage and proposes exposed neural tissue that the supplied MRI specifically excludes.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Neural crest; leakage from an exposed neural placode,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Neural crest; leakage from an exposed neural placode” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Neural crest; leakage from an exposed neural placode,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Neural crest; leakage from an exposed neural placode” remains viable only if both steps agree.

Takeaway: Vertebral lineage and biochemical exposure are separate judgments in skin-covered dysraphism.

Case sources: ^{[10] [28] [41]}

1. A. Request dating- and plurality-adjusted AFP interpretation and defer further anatomy unless AFP remains positive (Why this does not fit)

   Laboratory reinterpretation is appropriate, but unassessed fetal anatomy still requires completion even if the revised serum classification is negative.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Request dating- and plurality-adjusted AFP interpretation and defer further anatomy unless AFP remains positive,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Request dating- and plurality-adjusted AFP interpretation and defer further anatomy unless AFP remains positive” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Request dating- and plurality-adjusted AFP interpretation and defer further anatomy unless AFP remains positive,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Request dating- and plurality-adjusted AFP interpretation and defer further anatomy unless AFP remains positive” remains viable only if both steps agree.

2. B. Obtain amniotic AFP and acetylcholinesterase before completing the limited anatomical survey (Why this does not fit)

   Diagnostic fluid testing can have a role after counseling and imaging, but an incompletely assessed anatomy scan should be completed promptly rather than deferred in favor of an invasive test.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Obtain amniotic AFP and acetylcholinesterase before completing the limited anatomical survey,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Obtain amniotic AFP and acetylcholinesterase before completing the limited anatomical survey” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Obtain amniotic AFP and acetylcholinesterase before completing the limited anatomical survey,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Obtain amniotic AFP and acetylcholinesterase before completing the limited anatomical survey” remains viable only if both steps agree.

3. C. Use the original singleton AFP interpretation and complete detailed anatomy (Why this does not fit)

   Detailed anatomy is needed, but a threshold based on the wrong plurality and possibly wrong dating should not remain the biochemical interpretation.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Use the original singleton AFP interpretation and complete detailed anatomy,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Use the original singleton AFP interpretation and complete detailed anatomy” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Use the original singleton AFP interpretation and complete detailed anatomy,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Use the original singleton AFP interpretation and complete detailed anatomy” remains viable only if both steps agree.

4. D. Request dating- and plurality-adjusted AFP interpretation and promptly complete detailed anatomy (Best answer)

   Dating and twins affect serum interpretation, while incomplete spine views require structural assessment. Neither corrected biochemistry nor one limited scan substitutes for the other.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Request dating- and plurality-adjusted AFP interpretation and promptly complete detailed anatomy,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Request dating- and plurality-adjusted AFP interpretation and promptly complete detailed anatomy” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Request dating- and plurality-adjusted AFP interpretation and promptly complete detailed anatomy,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Request dating- and plurality-adjusted AFP interpretation and promptly complete detailed anatomy” remains viable only if both steps agree.

Takeaway: Correct the context of the serum screen while promptly completing the independent structural assessment.

Case sources: ^{[10] [11]}

1. A. Endochondral ossification; mesodermal posterior skull-base contribution (Best answer)

   The phenotype and FGFR3 result indicate achondroplasia with impaired cartilage-based bone growth. The bony craniocervical outlet localizes the problem to posterior skull-base components with mesodermal contribution, rather than proving that all cranial-base bones are mesodermal.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Endochondral ossification; mesodermal posterior skull-base contribution,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Endochondral ossification; mesodermal posterior skull-base contribution” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Endochondral ossification; mesodermal posterior skull-base contribution,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Endochondral ossification; mesodermal posterior skull-base contribution” remains viable only if both steps agree.

2. B. Intramembranous ossification; mesodermal posterior skull-base contribution (Why this does not fit)

   The regional origin fits, but FGFR3-related short-limb skeletal dysplasia primarily impairs growth through a cartilage model, not direct intramembranous bone formation.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Intramembranous ossification; mesodermal posterior skull-base contribution,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Intramembranous ossification; mesodermal posterior skull-base contribution” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Intramembranous ossification; mesodermal posterior skull-base contribution,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Intramembranous ossification; mesodermal posterior skull-base contribution” remains viable only if both steps agree.

3. C. Endochondral ossification; neural crest contribution (Why this does not fit)

   The growth process fits achondroplasia, but the specified posterior occipital skull-base region is predominantly mesodermal; the entire cranial base is not one lineage.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Endochondral ossification; neural crest contribution,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Endochondral ossification; neural crest contribution” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Endochondral ossification; neural crest contribution,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Endochondral ossification; neural crest contribution” remains viable only if both steps agree.

4. D. Intramembranous ossification; neural crest contribution (Why this does not fit)

   This better describes many facial and anterior vault elements, not the affected cartilage-based posterior skull-base component.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Intramembranous ossification; neural crest contribution,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Intramembranous ossification; neural crest contribution” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Intramembranous ossification; neural crest contribution,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Intramembranous ossification; neural crest contribution” remains viable only if both steps agree.

Takeaway: Combine the growth mechanism with regional skull-base anatomy; ossification mode and embryonic lineage are separate axes.

Case sources: ^{[5] [47]}

1. A. Posterior-column cord lesion; isolated vermian agenesis with an expanded posterior fossa (Why this does not fit)

   This predicts the wrong sensory modality loss and a less coherent explanation for the cough-triggered craniocervical symptoms.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Posterior-column cord lesion; isolated vermian agenesis with an expanded posterior fossa,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Posterior-column cord lesion; isolated vermian agenesis with an expanded posterior fossa” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Posterior-column cord lesion; isolated vermian agenesis with an expanded posterior fossa,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Posterior-column cord lesion; isolated vermian agenesis with an expanded posterior fossa” remains viable only if both steps agree.

2. B. Cervical central cord cavity; cerebellar tonsillar descent at the foramen magnum (Best answer)

   Dissociated shoulder-region sensory loss suggests syringomyelia, and its association with cough headache favors symptomatic Chiari I anatomy. Imaging is needed; symptoms alone do not establish it.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Cervical central cord cavity; cerebellar tonsillar descent at the foramen magnum,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cervical central cord cavity; cerebellar tonsillar descent at the foramen magnum” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Cervical central cord cavity; cerebellar tonsillar descent at the foramen magnum,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cervical central cord cavity; cerebellar tonsillar descent at the foramen magnum” remains viable only if both steps agree.

3. C. Cervical central cord cavity; isolated vermian agenesis with an expanded posterior fossa (Why this does not fit)

   The cavity fits dissociated sensory loss, but the hindbrain pattern is not the usual cough-headache and syrinx association.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Cervical central cord cavity; isolated vermian agenesis with an expanded posterior fossa,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Cervical central cord cavity; isolated vermian agenesis with an expanded posterior fossa” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Cervical central cord cavity; isolated vermian agenesis with an expanded posterior fossa,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Cervical central cord cavity; isolated vermian agenesis with an expanded posterior fossa” remains viable only if both steps agree.

4. D. Posterior-column cord lesion; cerebellar tonsillar descent at the foramen magnum (Why this does not fit)

   Tonsillar crowding can explain cough-provoked pain, but posterior-column damage would impair vibration and joint position, which are spared.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Posterior-column cord lesion; cerebellar tonsillar descent at the foramen magnum,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Posterior-column cord lesion; cerebellar tonsillar descent at the foramen magnum” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Posterior-column cord lesion; cerebellar tonsillar descent at the foramen magnum,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Posterior-column cord lesion; cerebellar tonsillar descent at the foramen magnum” remains viable only if both steps agree.

Takeaway: Localize the sensory pattern, then connect the likely syrinx to a craniocervical CSF-flow disorder.

Case sources: ^[13]

1. A. Expanded posterior fossa with a fourth-ventricle cyst; ventricular enlargement (Why this does not fit)

   A cystic expanded fossa can accompany hydrocephalus, but it is not the characteristic hindbrain association of the open lumbar lesion.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Expanded posterior fossa with a fourth-ventricle cyst; ventricular enlargement,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Expanded posterior fossa with a fourth-ventricle cyst; ventricular enlargement” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Expanded posterior fossa with a fourth-ventricle cyst; ventricular enlargement,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Expanded posterior fossa with a fourth-ventricle cyst; ventricular enlargement” remains viable only if both steps agree.

2. B. Expanded posterior fossa with a fourth-ventricle cyst; persistently small lateral ventricles (Why this does not fit)

   Neither the expected Chiari II architecture nor the likely hydrocephalus consequence is captured by this pair.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Expanded posterior fossa with a fourth-ventricle cyst; persistently small lateral ventricles,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Expanded posterior fossa with a fourth-ventricle cyst; persistently small lateral ventricles” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Expanded posterior fossa with a fourth-ventricle cyst; persistently small lateral ventricles,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Expanded posterior fossa with a fourth-ventricle cyst; persistently small lateral ventricles” remains viable only if both steps agree.

3. C. Crowded posterior fossa with abnormal hindbrain descent; ventricular enlargement (Best answer)

   Open myelomeningocele strongly associates with Chiari II anatomy; bulbar symptoms suggest hindbrain dysfunction and increasing head size suggests associated hydrocephalus.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Crowded posterior fossa with abnormal hindbrain descent; ventricular enlargement,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Crowded posterior fossa with abnormal hindbrain descent; ventricular enlargement” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Crowded posterior fossa with abnormal hindbrain descent; ventricular enlargement,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Crowded posterior fossa with abnormal hindbrain descent; ventricular enlargement” remains viable only if both steps agree.

4. D. Crowded posterior fossa with abnormal hindbrain descent; persistently small lateral ventricles (Why this does not fit)

   The hindbrain prediction fits, but persistently small ventricles do not account well for the progressive pressure-related head enlargement.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Crowded posterior fossa with abnormal hindbrain descent; persistently small lateral ventricles,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Crowded posterior fossa with abnormal hindbrain descent; persistently small lateral ventricles” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Crowded posterior fossa with abnormal hindbrain descent; persistently small lateral ventricles,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Crowded posterior fossa with abnormal hindbrain descent; persistently small lateral ventricles” remains viable only if both steps agree.

Takeaway: Use the open spinal lesion to predict hindbrain architecture, and independently use evolving head size to predict ventricular consequences.

Case sources: ^{[10] [13] [41]}

1. A. Blake pouch cyst; lateral and third enlargement with a nondilated fourth (Why this does not fit)

   This misclassifies the dysplastic vermis and also applies an aqueduct-obstruction pattern despite the established patent aqueduct and distal blockage.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Blake pouch cyst; lateral and third enlargement with a nondilated fourth,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Blake pouch cyst; lateral and third enlargement with a nondilated fourth” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Blake pouch cyst; lateral and third enlargement with a nondilated fourth,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Blake pouch cyst; lateral and third enlargement with a nondilated fourth” remains viable only if both steps agree.

2. B. Blake pouch cyst; enlargement of lateral, third and fourth ventricles (Why this does not fit)

   Distal egress obstruction permits all upstream ventricles to enlarge, but a Blake pouch cyst ordinarily has a formed, relatively normal vermis rather than this dysplastic vermian pattern.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Blake pouch cyst; enlargement of lateral, third and fourth ventricles,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Blake pouch cyst; enlargement of lateral, third and fourth ventricles” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Blake pouch cyst; enlargement of lateral, third and fourth ventricles,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Blake pouch cyst; enlargement of lateral, third and fourth ventricles” remains viable only if both steps agree.

3. C. Dandy-Walker malformation; lateral and third enlargement with a nondilated fourth (Why this does not fit)

   The malformation fits the vermian anatomy, but a fourth ventricle upstream of obstructed exits is not protected from dilation.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Dandy-Walker malformation; lateral and third enlargement with a nondilated fourth,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Dandy-Walker malformation; lateral and third enlargement with a nondilated fourth” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Dandy-Walker malformation; lateral and third enlargement with a nondilated fourth,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Dandy-Walker malformation; lateral and third enlargement with a nondilated fourth” remains viable only if both steps agree.

4. D. Dandy-Walker malformation; enlargement of lateral, third and fourth ventricles (Best answer)

   The vermian and fourth-ventricular anatomy supports Dandy-Walker malformation. The specifically established distal obstruction places all ventricular levels upstream. This mechanism is given for this case, not asserted for every Dandy-Walker malformation.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Dandy-Walker malformation; enlargement of lateral, third and fourth ventricles,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Dandy-Walker malformation; enlargement of lateral, third and fourth ventricles” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Dandy-Walker malformation; enlargement of lateral, third and fourth ventricles,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Dandy-Walker malformation; enlargement of lateral, third and fourth ventricles” remains viable only if both steps agree.

Takeaway: Classify the posterior-fossa malformation and separately trace the demonstrated CSF obstruction.

Case sources: ^{[1] [14] [37]}

1. A. Failure of prosencephalic separation; fused deep forebrain structures (Best answer)

   The chromosome and facial pattern suggests holoprosencephaly; severe failure of forebrain separation can produce fused thalami and a poorly divided ventricular cavity.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “Failure of prosencephalic separation; fused deep forebrain structures,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Failure of prosencephalic separation; fused deep forebrain structures” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “Failure of prosencephalic separation; fused deep forebrain structures,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Failure of prosencephalic separation; fused deep forebrain structures” remains viable only if both steps agree.

2. B. Failure of prosencephalic separation; an isolated posterior-fossa arachnoid cyst (Why this does not fit)

   The developmental process is plausible, but an isolated extra-axial posterior-fossa cyst would not confirm the predicted forebrain nonseparation.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “Failure of prosencephalic separation; an isolated posterior-fossa arachnoid cyst,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Failure of prosencephalic separation; an isolated posterior-fossa arachnoid cyst” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “Failure of prosencephalic separation; an isolated posterior-fossa arachnoid cyst,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Failure of prosencephalic separation; an isolated posterior-fossa arachnoid cyst” remains viable only if both steps agree.

3. C. Failure of cranial neural-tube closure; absent major cranial vault structures (Why this does not fit)

   That pairing fits an anencephaly spectrum rather than an intact vault with this forebrain-midline pattern.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “Failure of cranial neural-tube closure; absent major cranial vault structures,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Failure of cranial neural-tube closure; absent major cranial vault structures” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “Failure of cranial neural-tube closure; absent major cranial vault structures,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Failure of cranial neural-tube closure; absent major cranial vault structures” remains viable only if both steps agree.

4. D. Failure of cranial neural-tube closure; fused deep forebrain structures (Why this does not fit)

   The predicted deep midline fusion fits holoprosencephaly, but failure of cranial tube closure is a different process.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “Failure of cranial neural-tube closure; fused deep forebrain structures,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “Failure of cranial neural-tube closure; fused deep forebrain structures” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “Failure of cranial neural-tube closure; fused deep forebrain structures,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “Failure of cranial neural-tube closure; fused deep forebrain structures” remains viable only if both steps agree.

Takeaway: Use the facial and chromosome findings to predict a forebrain process, then name an imaging result that would actually confirm it.

Case sources: ^{[12] [38]}

1. A. 400 micrograms daily, beginning after the first prenatal ultrasound (Why this does not fit)

   This combines the routine dose with delayed initiation, so neither the recurrence-risk dose nor the preventive timing is matched.

   Reasoning steps for option A

   1. What stem feature must be localized before judging option A, “400 micrograms daily, beginning after the first prenatal ultrasound,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “400 micrograms daily, beginning after the first prenatal ultrasound” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option A, “400 micrograms daily, beginning after the first prenatal ultrasound,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “400 micrograms daily, beginning after the first prenatal ultrasound” remains viable only if both steps agree.

2. B. 4,000 micrograms daily, beginning at least 1 month before conception (Best answer)

   A prior affected pregnancy changes the recommended dose, and preconception initiation is important because neural tube closure occurs early. The cited CDC guidance continues this regimen through the first 3 months of pregnancy under clinician supervision.

   Reasoning steps for option B

   1. What stem feature must be localized before judging option B, “4,000 micrograms daily, beginning at least 1 month before conception,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “4,000 micrograms daily, beginning at least 1 month before conception” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option B, “4,000 micrograms daily, beginning at least 1 month before conception,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “4,000 micrograms daily, beginning at least 1 month before conception” remains viable only if both steps agree.

3. C. 400 micrograms daily, beginning at least 1 month before conception (Why this does not fit)

   The preconception timing is appropriate, but CDC recurrence-prevention guidance uses a higher folic acid dose after a prior neural-tube-defect-affected pregnancy.

   Reasoning steps for option C

   1. What stem feature must be localized before judging option C, “400 micrograms daily, beginning at least 1 month before conception,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “400 micrograms daily, beginning at least 1 month before conception” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option C, “400 micrograms daily, beginning at least 1 month before conception,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “400 micrograms daily, beginning at least 1 month before conception” remains viable only if both steps agree.

4. D. 4,000 micrograms daily, starting after the first ultrasound (Why this does not fit)

   The recurrence-prevention dose is appropriate, but starting after the first ultrasound is too late for a process that closes very early in embryonic development.

   Reasoning steps for option D

   1. What stem feature must be localized before judging option D, “4,000 micrograms daily, starting after the first ultrasound,” in this vignette?

      Start with the raw clinical or experimental finding, then test whether the structure or process proposed by “4,000 micrograms daily, starting after the first ultrasound” occupies the same anatomical or cellular compartment.

   2. What second developmental check separates option D, “4,000 micrograms daily, starting after the first ultrasound,” from the competing choices?

      After localization, compare the proposed lineage, derivative, evidence scope, or timing rule with the stem; “4,000 micrograms daily, starting after the first ultrasound” remains viable only if both steps agree.

Takeaway: Recurrence history changes dose, and early closure changes when prevention must start.

Case sources: ^{[15] [39]}